 
Clinicians Connect: Conversations with FDA's Chief Medical Officer
September 25, 2024, 11 a.m. - Noon
Are you a health care professional and want to learn more about the current state of the opioid crisis and what we can do to prevent drug overdoses and reduce deaths? Join us on Wednesday, September 25 at 11 a.m. EDT to hear directly from the FDA, SAMHSA and NIH about the latest in overdose prevention.
Presenters will provide the latest information on the drug overdose crisis, how government agencies are working together to help health care professionals, and resources you can use today in your practice, including free training.
Presenters:
Hilary Marston, MD, MPH
Chief Medical Officer, Office of the Commissioner, FDA
Josh Rising, MD, MPH
Senior Clinical Advisor, Office of the Commissioner, FDA
Marta Sokolowska, PhD
Deputy Center Director for Substance Use and Behavioral Health, Center for Drug Evaluation and Research, FDA
CAPT Christopher M. Jones, PharmD, DrPH, MPH
Director, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration
Wilson M. Compton, MD, MPE
Deputy Director, National Institute on Drug Abuse, National Institutes of Health
To stay informed about future Clinicians Connect: Conversations with FDA's Chief Medical Officer, please subscribe to our mailing list.
About Us
The Stakeholder Engagement Staff resides within the Office of the Commissioner and falls under the Office of External Affairs. We aim to build stronger relationships with health professional organizations, consumer groups, trade associations, patient advocacy organizations, think tanks/academia, and other stakeholders, in order to better inform our policy making process, identify policy hurdles or stakeholder misconceptions, and create strategic collaborations. For more information, please contact us at FDAStakeholderEngagement@fda.hhs.gov.
|
